Skip to main content
logo
Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
3.250
+0.020 (0.62%)
Sep 2, 2026, 10:54 AM AEST

Mayne Pharma Group Revenue

In the fiscal year ending June 30, 2026, Mayne Pharma Group had annual revenue of 383.68M AUD, down -5.98%. Mayne Pharma Group had revenue of 171.61M in the half year ending June 30, 2026, a decrease of -14.40%.

Revenue
383.68M
Revenue Growth
-5.98%
P/S Ratio
0.68
Revenue / Employee
1.06M
Employees
491
Market Cap
262.42M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2026383.68M-24.42M-5.98%
Jun 30, 2025408.10M19.70M5.07%
Jun 30, 2024388.40M204.81M111.56%
Jun 30, 2023183.59M26.44M16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CSL Limited22.83B
Ramsay Health Care18.58B
Sigma Healthcare10.83B
Paragon Care3.68B
Monash IVF Group269.39M
Pro Medicus261.69M
Aroa Biosurgery86.47M
BLS Pharmaceuticals47.95M
Revenue Rankings

Mayne Pharma Group News

More News